|
ARL13B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.50640000000336E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34180000000728E-05 |
| Normal-vs-Stage2 |
9.960600E-01 |
| Normal-vs-Stage3 |
6.898900E-03 |
| Normal-vs-Stage4 |
1.347840E-02 |
| Stage1-vs-Stage2 |
9.935100E-03 |
| Stage1-vs-Stage3 |
7.027000E-01 |
| Stage1-vs-Stage4 |
6.168200E-01 |
| Stage2-vs-Stage3 |
2.942300E-02 |
| Stage2-vs-Stage4 |
4.285700E-02 |
| Stage3-vs-Stage4 |
9.050400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.13830000000059E-05 |
| Normal-vs-AfricanAmerican |
1.478470E-02 |
| Normal-vs-Asian |
8.659300E-03 |
| Caucasian-vs-AfricanAmerican |
1.689020E-01 |
| Caucasian-vs-Asian |
8.147800E-01 |
| AfricanAmerican-vs-Asian |
3.371000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.280330E-02 |
| Normal-vs-Female |
6.01350000000167E-05 |
| Male-vs-Female |
2.148800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.31600000000221E-06 |
| Normal-vs-Age(41-60Yrs) |
2.422800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.568200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.866600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.646500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.998800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.123600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.074200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.782400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.284000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.310200E-01 |
| Classical-VS-Follicular |
2.15893969368608E-12 |
| Classical-VS-Other |
7.516800E-01 |
| Classical-VS-Normal |
1.15189999982945E-07 |
| Tall-VS-Follicular |
3.55260000306501E-08 |
| Tall-VS-Other |
5.978200E-01 |
| Tall-VS-Normal |
5.68679999999322E-05 |
| Follicular-VS-Other |
2.114400E-01 |
| Follicular-VS-Normal |
5.105500E-02 |
| Other-VS-Normal |
4.014000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.227400E-01 |
| Normal-vs-N1 |
1.657910E-02 |
| N0-vs-N1 |
4.560100E-02 |
|
|
